gastroenteritis%20-%20parasitic
GASTROENTERITIS - PARASITIC
Frequently, patients with gastrointestinal parasitic infections do not have any signs and symptoms that are specific for parasitic infections (eg fever, malaise, fatigue, sweating, wt loss, anorexia, edema, pruritus).
Some patients may be asymptomatic.
Gastrointestinal symptoms, if present, include diarrhea, abdominal pain, dysentery, flatulence, jaundice, rectal prolapse, dyspepsia, malabsorption, vomiting and biliary colic. 

Introduction

  • Parasites causing gastrointestinal symptoms may be transmitted to humans via the fecal-oral route by food or water ingestion, or by skin penetration

Etiology

Parasites according to their mode of transmission

  • Soil-transmitted helminths: Ascaris lumbricoides, Ancylostoma duodenale, Necator americanus, Strongyloides stercoralis, Trichuris trichiura
  • Food-borne trematodes: Clonorchis sinensis, Opisthorchis viverrini, Fasciola hepatics, Paragonimus sp.
  • Water-borne parasites: Schistosoma haematobium/japonicum/mansoni, Cryptosporidium sp., Giardia lamblia, Entamoeba histolytica

Signs and Symptoms

  • Frequently, patients w/ gastrointestinal parasitic infections do not have any signs & symptoms that are specific for parasitic infections (eg fever, malaise, fatigue, sweating, weight loss, anorexia, edema, pruritus)
  • Some patients may be asymptomatic
  • Gastrointestinal symptoms, if present, include diarrhea, abdominal pain, dysentery, flatulence, jaundice, rectal prolapse, dyspepsia, malabsorption, vomiting & biliary colic
  • Extraintestinal infection can also occur & may give rise to symptoms (eg headache, seizures, cough, dyspnea, hemoptysis, wheezing, vulvovaginitis, dysuria, hematuria, skin rashes, pruritus, arthralgia, anemia, fatigue & claudication)

Risk Factors

Host Susceptibility Factors in Gastrointestinal Parasitic Infections

  • Nutritional status
  • Immunosuppressive drugs
  • Age (newborn)
  • Intercurrent disease
  • Presence of a malignancy
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 4 days ago

Individuals with moderate-to-severe plaque psoriasis may reap better long-term improvements in the severity of their condition when treated with guselkumab over secukinumab, according to findings of the phase III ECLIPSE* trial presented at the recent Inflammatory Skin Disease Summit (ISDS 2018) held in Vienna, Austria.

Jairia Dela Cruz, 11 Jan 2019
Use of standard-dose aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to confer protection against the risk of endometrial cancer in overweight and obese women, according to a meta-analysis.
Elvira Manzano, 5 days ago
Treatment with two investigational, oral JAK inhibitors may be beneficial in individuals with moderate‐to‐severe alopecia areata (spot baldness), an autoimmune disease that can cause a lot of anxiety, according to an ongoing phase II study.
3 days ago
Discontinuing the use of tyrosine kinase inhibitors (TKIs) in the treatment of patients with chronic myeloid leukaemia appears to be feasible in real-life clinical practice in the context of close molecular monitoring, a study reports.